FindTrial
Sign In

The effect of hyoscine butyl bromide on the duration of the first stage of labor in term pregnant women at rural tertiary care centre: A randomized placebo-controlled trial.

The effect of hyoscine butyl bromide on the duration of the first stage of labor in term pregnant women at rural tertiary care centre: A randomized placebo-controlled trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104014
Enrollment
152
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hyoscine Butyl Bromide: All primigravida women with 37 to 42 weeks pregnancy in active labor will be selected . At the initiation of the active phase of labour study group will be given

Sponsors

Uttar Pradesh University of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primigravida women Age 18-35 years Gestational age 37-42 weeks Singleton pregnancy Vertex presentation

Exclusion criteria

Exclusion criteria: Multifetal gestation Malpresentation / Malposition Preterm labour / Preterm prelabour rupture of membrane Cephalopelvic disproportion Antepartum hemorrhage Patient who underwent epidural anesthesia or any other type of anesthesia Contraindication for hyoscine butyl bromide which includes allergy to the hyoscine and other atropinics Patient not giving consent

Design outcomes

Primary

MeasureTime frame
It is expected that Hyoscine butyl bromide might help in shortening the duration of first stage of labour in term pregnant women in active labourTimepoint: Time will be noted at cervical dilatation at 4 cm and then at full dilatation . Difference of time interval will help to calculate the duration of first stage of labour in both control and test groups—

Secondary

MeasureTime frame
Timepoint: ;NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Shubhranshi Gaur

UTTAR PRADESH UNIVERSITY OF MEDICAL SCIENCES SAIFAI ETAWAH

soniyaramesh17@gmail.com9870622275

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026